BEAM

Beam Therapeutics Inc

1 day chart

About BEAM

Beam Therapeutics Inc. is a biotechnology company engaged in providing life-long cures to patients suffering from serious diseases. The Company operates a fully integrated platform for precision genetic medicines. Its base editing technology enables a differentiated class of precision genetic medicines that target a single base in the genome without making a double-stranded break in the deoxyribonucleic acid (DNA). The Company is advancing its base editing technology across three disease-area portfolios: hematology, immunology/oncology and genetic diseases. Its clinical-stage programs include BEAM-101, BEAM-201, BEAM-301 and BEAM-302. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy designed to offer a profile, incorporating base edits that are intended to mimic single nucleotide polymorphisms seen in individuals with hereditary persistence of fetal hemoglobin (HPFH). BEAM-201 is a development candidate comprised of T cells.

Buy US stocks in Australia starting with BEAM. Open an account and start investing today!

Market Capitalisation

$2.47B

Price-earnings ratio

Dividend yield

0.00%

Volume

7.43K

High today

$32.67

Low today

$31.53

Open price

$31.53

52-week high

$0.00

52-week low

$0.00

BEAM FAQs

Can I buy BEAM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy BEAM shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Beam Therapeutics Inc?

One share of Beam Therapeutics Inc is valued at $32.38.

What is the ticker symbol for Beam Therapeutics Inc?

The ticker symbol for Beam Therapeutics Inc is BEAM.

How do I buy BEAM shares in Australia?

To buy BEAM stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in BEAM

What is the 52-week high for Beam Therapeutics Inc stock?

The Beam Therapeutics Inc 52-week high stock price is $0.00.

What is the 52-week low for Beam Therapeutics Inc stock?

The Beam Therapeutics Inc 52-week low stock price is $0.00.

What is the market capitalisation of Beam Therapeutics Inc BEAM?

As of 27/05/2023 Beam Therapeutics Inc has a market cap of $2.5B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.